Keyphrases
Tumor-infiltrating Lymphocytes
79%
Metastatic Melanoma
73%
Melanoma
67%
Chimeric Antigen Receptor T Cells (CAR-T)
59%
T Cells
54%
Adoptive Cell Therapy
49%
Melanoma Cells
41%
Melanoma Patients
37%
Salmonella Enterica Serovar Typhimurium (S. Typhimurium)
31%
Israel
29%
Myxococcus Xanthus
29%
Macrophages
28%
CEACAM1
28%
Salmonella
27%
Tumor
25%
Escherichia Coli
23%
Liver
23%
MicroRNA
22%
Salmonella Enterica
21%
Serovars
21%
Antibiotics
21%
Virulence
20%
Inflammation
20%
Extended-spectrum-lactamase
19%
SPI1
19%
Ly6Chi Monocytes
19%
Chimeric Antigen Receptor T-cell Therapy
19%
Clinical Trials
18%
Complete Response
18%
Adoptive Cell Transfer
18%
Polyketide Antibiotics
18%
CD19 chimeric Antigen Receptor T Cells
18%
Immune Checkpoint Inhibitors
17%
Non-typhoidal Salmonella
17%
Salmonella Enterica Serovar Infantis
16%
Colorectal Cancer
15%
In Cancer
15%
Risk Factors
15%
Ipilimumab
15%
Motility
15%
Enterobacteriaceae
15%
Bacterial Pathogens
14%
Kupffer Cells
14%
Glucose-dependent Insulinotropic Polypeptide
14%
Clinical Response
14%
Legionella Pneumophila
14%
Cell Adhesion Molecule 1 (CADM1)
14%
Carcinoembryonic Antigen
14%
T Cell Activation
14%
Pathogenicity
14%
Overall Survival
14%
Extracellular Matrix
13%
CD28
13%
Monocytes
12%
Advanced Melanoma
12%
Programmed Death-ligand 1 (PD-L1)
12%
Type 3 Secretion System (T3SS)
12%
Disease Progression
12%
CD19
12%
Virulence Genes
12%
Antitumor
12%
Immune Cells
11%
Tumor Growth
11%
Autoimmune Disease
11%
Anti-CD19 chimeric Antigen Receptor T Cells
11%
Adoptive Transfer
11%
Salmonella Paratyphi
11%
Adverse Events
11%
Natural Killer Cells
11%
BRAF Inhibitor (BRAFi)
11%
Salmonella Serovars
11%
Acute Lymphoblastic Leukemia
11%
COMMD10
10%
Autoreactive T Cells
10%
Meta-analysis
10%
Systemic Lupus Erythematosus
10%
Virulence Regulation
10%
Constitutively Active
10%
Cancer Patients
10%
Malignant Melanoma
10%
Plasmid
10%
Colon
10%
Durable Response
10%
Odds Ratio
10%
Anti-melanoma
9%
Melanoma Treatment
9%
CD8+ T Cells
9%
ADAR1
9%
Confidence Interval
9%
Genetic Modification
9%
Overall Response Rate
9%
Regulatory T Cells
9%
DksA
9%
Persistent Infection
9%
Tumor Progression
9%
B-cell Malignancies
9%
Murine Model
9%
Autoimmunity
8%
Host Cell Invasion
8%
Therapeutic Potential
8%
Immunology and Microbiology
T Cell
77%
Salmonella
64%
Macrophage
54%
Mouse
54%
Tumor-Infiltrating Lymphocytes
51%
Immunotherapy
45%
Melanoma Cell
38%
Monocyte
31%
CD19
31%
Escherichia coli
30%
Chimeric Antigen Receptor T-Cell
29%
Tumor-Associated Macrophage
28%
Infectious Agent
27%
Immunocompetent Cell
23%
Host Cell
22%
Salmonella enterica
21%
CEACAM1
20%
Serotype
20%
Gene Expression
19%
Colitis
19%
Promoter Region
18%
Myxococcus xanthus
18%
B Cell
18%
Chimeric Antigen Receptor
17%
Plasmid
17%
Salmonella Enterica Serovar Infantis
17%
Transfer Cell
16%
Cytokine
16%
Salmonella Enterica Serovar Typhimurium
16%
Pathogenicity
16%
Pathogenicity Island
15%
Kupffer Cell
14%
Chimeric Antigen Receptor T-Cell Therapy
14%
Regulatory T Cell
14%
Legionella pneumophila
14%
Natural Killer Cell
14%
Colon
13%
Enterobacteriaceae
13%
Antimicrobial Resistance
12%
Prevalence
12%
Gene Cluster
12%
Lymphocyte
11%
Extracellular Matrix
11%
Gene Control
11%
Systemic Lupus Erythematosus
11%
CD28
11%
Adipose Tissue
11%
Downregulation
11%
Cell Invasion
11%
Cytotoxic T-Cell
11%
Carcinoembryonic Antigen
10%
Salmonella Enterica Serovar Paratyphi A
10%
Cell Adhesion Molecule 1
10%
Lineages
10%
Autoimmune Disease
10%
Ipilimumab
10%
Immune Response
9%
Neoantigen
9%
Body Weight
9%
Secretion (Process)
9%
Inflammatory Bowel Disease
9%
Type Three Secretion System
9%
Autoimmunity
9%
Myeloid
9%
Overall Survival
8%
Whole Genome Sequencing
8%
Electroporation
8%
Host Range
8%
Fimbria
7%
Biofilm
7%
Drug Megadose
7%
Immunity
7%
Cell Proliferation
7%
Regulon
7%
Eosinophil Granulocyte
7%
Bioluminescence
7%
Sparrow
7%
Cell Motility
7%
Virulence Plasmid
7%
Hematopoietic Stem Cell
7%
Gene Product
7%
Enterobacterales
7%
Bird
7%
Foal
7%
Adenosine Deaminase
7%
Oxidative Stress
7%
Mouse Model
7%
Interleukin 2
7%
White Adipose Tissue
6%
Transcription Factors
6%
Wild Type
6%
Cell Activity
6%
Tumor Necrosis Factor
6%
Interleukin-6
6%
Acanthamoeba castellanii
6%
Neutrophil Granulocyte
6%
Single Nucleotide Polymorphism
6%
Protein Binding
6%
Cell Metabolism
6%
Adjuvant
6%
Medicine and Dentistry
Nodular Melanoma
100%
Metastatic Melanoma
61%
Immunotherapy
60%
Neoplasm
56%
Tumor Infiltrating Lymphocyte
47%
T Cell
46%
Chimeric Antigen Receptor T-Cell
46%
Malignant Neoplasm
34%
Disease
32%
Cell Therapy
30%
Clinical Trial
25%
Chimeric Antigen Receptor
23%
Carcinoembryonic Antigen Related Cell Adhesion Molecule 1
23%
Melanoma Cell
21%
Adverse Event
19%
Immune Checkpoint Inhibitor
18%
microRNA
18%
Transfer Cell
16%
Acute Lymphoblastic Leukemia
15%
Overall Survival
14%
Salmonella
14%
Chimeric Antigen Receptor T-Cell Immunotherapy
13%
Lymphocyte
12%
Ipilimumab
12%
Progression Free Survival
11%
Pathogenicity Island
11%
Host Cell
11%
Infection
11%
Immunocompetent Cell
11%
Tumor Progression
10%
Cytotoxic T-Cell
10%
Receptor
10%
Epithelial Cell
9%
Disease Exacerbation
9%
Oncology
9%
Metastatic Carcinoma
9%
Infusion
9%
Large-Cell Lymphoma
9%
Cell Invasion
9%
Gastric Inhibitory Polypeptide
9%
Macrophage
8%
Colitis
8%
Adoptive Transfer
8%
Cohort Effect
8%
Randomized Clinical Trial
7%
Side Effect
7%
Immune Response
7%
Cancer
7%
Cell Motility
7%
Cell Adhesion Molecule 1
7%
Indocyanine Green
7%
Pericardial Fluid
7%
Sepsis
7%
Carcinoembryonic Antigen
7%
Meta-Analysis
7%
Very Low Birth Weight
7%
Pleura Mesothelioma
7%
Integrin
7%
Salmonella Enterica Serovar Paratyphi A
7%
B-Cell Lymphoma
7%
Colonoscopy
7%
Prevalence
7%
Surgery
7%
Colon
6%
T Lymphocyte
6%
Intention-to-Treat Analysis
6%
Liposome
6%
Diagnosis
6%
Interleukin 2
6%
Biological Marker
6%
Nivolumab
6%
Lung Metastasis
6%
Leukapheresis
6%
Serotype
6%
Thrombocytopenia
5%
Fibrosis
5%
Drug Megadose
5%
Extracellular Matrix
5%
Gut
5%
Lactate Dehydrogenase
5%
Salvage Therapy
5%
Cross Sectional Study
5%
Primary Tumor
5%
Inflammatory Bowel Disease
5%
Non Small Cell Lung Cancer
5%
Body Weight
5%
Leukemia
5%
Retrospective Study
5%
Targeted Therapy
5%
Lymphocyte Culture
5%
Tumor Imaging
5%
Pediatrics Patient
5%
Rectum Cancer
5%
Rectum Tumor
5%